CIK: 0001831942 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $656,835 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XENE | XENON PHARMACEUTICALS INC | 1,845,000 | $66,033 | 10.1% | $26.06 | +41.8% | COM | 98420N105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,189,659 | $55,705 | 8.5% | $17.59 | +82.3% | COM | 92790C104 |
| — | MERUS N V | 2,950,000 | $54,280 | 8.3% | $24.11 | — | COM | N5749R100 |
| COGT | COGENT BIOSCIENCES INC | 4,772,421 | $51,494 | 7.8% | $8.50 | +50.5% | COM | 19240Q201 |
| — | BELLUS HEALTH INC NEW | 6,579,359 | $47,371 | 7.2% | $7.56 | — | COM NEW | 07987C204 |
| — | AMBRX BIOPHARMA INC | 4,803,447 | $42,847 | 6.5% | $8.92 | — | SPONSORED ADS | 02290A102 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,731,365 | $37,917 | 5.8% | $20.34 | 0.0% | COM | 29337E102 |
| — | AKERO THERAPEUTICS INC | 790,000 | $30,225 | 4.6% | $35.40 | — | COM | 00973Y108 |
| NUVL | NUVALENT INC | 1,075,000 | $28,047 | 4.3% | $28.14 | +5.1% | COM | 670703107 |
| IMVT | IMMUNOVANT INC | 1,440,999 | $22,350 | 3.4% | $13.55 | +28.1% | COM | 45258J102 |
| VERA | VERA THERAPEUTICS INC | 2,824,029 | $21,914 | 3.3% | $7.72 | 0.0% | CL A | 92337R101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 853,884 | $18,034 | 2.7% | $22.91 | +8.6% | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 495,823 | $17,840 | 2.7% | $30.35 | +42.2% | COM NEW | 15117B202 |
| — | CYMABAY THERAPEUTICS INC | 2,025,000 | $17,658 | 2.7% | $4.40 | — | COM | 23257D103 |
| CABA | CABALETTA BIO INC | 1,835,000 | $15,175 | 2.3% | $6.21 | +50.7% | COM | 12674W109 |
| KURA | KURA ONCOLOGY INC | 1,204,958 | $14,737 | 2.2% | $14.26 | -12.5% | COM | 50127T109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 575,000 | $14,605 | 2.2% | $36.39 | -13.6% | COM | 04280A100 |
| CELC | CELCUITY INC | 1,390,772 | $14,255 | 2.2% | $20.36 | -46.2% | COM | 15102K100 |
| — | PROMETHEUS BIOSCIENCES INC | 127,156 | $13,646 | 2.1% | $0.11 | — | COM | 74349U108 |
| — | ALPINE IMMUNE SCIENCES INC | 1,325,000 | $10,229 | 1.6% | $7.20 | — | COM | 02083G100 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 739,661 | $9,889 | 1.5% | $10.33 | +89.2% | COM | 23954D109 |
| RNAM | AVIDITY BIOSCIENCES INC | 590,705 | $9,067 | 1.4% | $14.91 | +47.6% | COM | 05370A108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 217,253 | $8,786 | 1.3% | $51.53 | -7.3% | COM | 29251M106 |
| — | ALLAKOS INC | 1,900,000 | $8,455 | 1.3% | $5.89 | — | COM | 01671P100 |
| PCVX | VAXCYTE INC | 200,000 | $7,496 | 1.1% | $39.66 | +6.9% | COM | 92243G108 |
| ACRS | ACLARIS THERAPEUTICS INC | 635,000 | $5,137 | 0.8% | $12.97 | -2.2% | COM | 00461U105 |
| — | THIRD HARMONIC BIO INC | 993,294 | $4,092 | 0.6% | $18.97 | — | COM | 88427A107 |
| — | ADVERUM BIOTECHNOLOGIES INC | 5,000,000 | $3,587 | 0.5% | $0.72 | — | COM | 00773U108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 312,553 | $2,457 | 0.4% | $24.62 | -69.7% | COM | 483497103 |
| RZLT | REZOLUTE INC | 898,267 | $1,725 | 0.3% | $3.32 | -32.3% | COM NEW | 76200L309 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 400,000 | $1,624 | 0.2% | $5.74 | -8.9% | COM | 00509G209 |
| — | DBV TECHNOLOGIES S A | 92,687 | $157 | 0.0% | $0.00 | — | SPONSORED ADR | 23306J101 |